Are patterns of HER-2/neu amplification and expression among primary tumors and regional metastases indicative of those in distant metastases and predictive of herceptin response?

被引：18

作者：

Thor, A ^{[1
]}

机构：

[1] Univ Oklahoma, Coll Med, Oklahoma City, OK 73104 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 15期

关键词：

D O I：

10.1093/jnci/93.15.1120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1120 / 1121

页数：2

共 11 条

[1]

Birner P, 2001, CLIN CANCER RES, V7, P1669

[2] Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status? [J].

Clark, GM .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1320-1321

[3]

Edgerton S. M., 2000, Breast Cancer Research and Treatment, V64, P55

[4]

Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966

[5] PROGNOSTIC IMPORTANCE OF C-ERBB-2 EXPRESSION IN BREAST-CANCER [J].

GUSTERSON, BA ;

GELBER, RD ;

GOLDHIRSCH, A ;

PRICE, KN ;

SAVESODERBORGH, J ;

ANBAZHAGAN, R ;

STYLES, J ;

RUDENSTAM, CM ;

GOLOUH, R ;

REED, R ;

MARTINEZTELLO, F ;

TILTMAN, A ;

TORHORST, J ;

GRIGOLATO, P ;

BETTELHEIM, R ;

NEVILLE, AM ;

BURKI, K ;

CASTIGLIONE, M ;

COLLINS, J ;

LINDTNER, J ;

SENN, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1049-1056

[6] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer [J].

Jacobs, TW ;

Gown, AM ;

Yaziji, H ;

Barnes, MJ ;

Schnitt, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1974-1982

[7] erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer [J].

Paik, SM ;

Bryant, J ;

Park, CH ;

Fisher, B ;

Tan-Chiu, E ;

Hyams, D ;

Fisher, ER ;

Lippman, ME ;

Wickerham, DL ;

Wolmark, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1361-1370

[8] Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer [J].

Simon, R ;

Nocito, A ;

Hübscher, T ;

Bucher, C ;

Torhorst, J ;

Schraml, P ;

Bubendorf, L ;

Mihatsch, MM ;

Moch, H ;

Wilber, K ;

Schötzau, A ;

Kononen, J ;

Sauter, G .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (15) :1141-1146

[9] Tyrosine kinase signalling in breast cancer - ErbB family receptor tyrosine kinases [J].

Stern, DF .

BREAST CANCER RESEARCH, 2000, 2 (03) :176-183

[10] erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer [J].

Thor, AD ;

Berry, DA ;

Budman, DR ;

Muss, HB ;

Kute, T ;

Henderson, IC ;

Barcos, M ;

Cirrincione, C ;

Edgerton, S ;

Allred, C ;

Norton, L ;

Liu, ET .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1346-1360

← 1 2 →